Group structure
2 companies in 2 countries
Canada1
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 192
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAZOLAMIDE FOR INJECTION, USP500 mg / vial · Powder For Solution | Acetazolamide | Canada | Not marketed | 2010 |
| ACETYLCYSTEINE SOLUTION USP200 mg / ml · Solution | Acetylcysteine | Canada | Marketed | 2024 |
| ACYCLOVIR SODIUM INJECTION50 mg / ml · Solution | Aciclovir | Canada | Not marketed | 2018 |
| AMMIVO100 mg / ml + 100 mg / ml · Solution | Benzoato, Phenylacetate | Canada | Authorised | |
| AMPHOTERICIN B FOR INJECTION, USP50 mg / vial · Powder For Solution | Amphotericin b | Canada | Authorised | |
| AMPICILLIN FOR INJECTION, USP500 mg / vial · Powder For Solution | Ampicillin | Canada | Authorised | |
| AMPICILLIN FOR INJECTION, USP1 g / vial · Powder For Solution | Ampicillin | Canada | Authorised | |
| AMPICILLIN FOR INJECTION, USP10 g / vial · Powder For Solution | Ampicillin | Canada | Authorised | |
| AMPICILLIN FOR INJECTION, USP250 mg / vial · Powder For Solution | Ampicillin | Canada | Authorised | |
| AMPICILLIN FOR INJECTION, USP2 g / vial · Powder For Solution | Ampicillin | Canada | Authorised | |
| APRESOLINE20 mg / ml · Solution | Hydralazine | Canada | Not marketed | 1992 |
| ARSENIC TRIOXIDE FOR INJECTION1 mg / ml · Solution | Arsenicum album | Canada | Marketed | 2019 |
| AZACITIDINE FOR INJECTION150 mg / vial · Powder For Suspension | Azacitidine | Canada | Authorised | |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canada | Authorised | |
| AZITHROMYCIN FOR INJECTION500 mg / vial · Powder For Solution | Azithromycin | Canada | Not marketed | 2011 |
| AZITHROMYCIN FOR INJECTION USP500 mg / vial · Powder For Solution | Azithromycin | Canada | Marketed | 2019 |
| BACIJECT50000 unit / vial · Powder For Solution | Bacitracin | Canada | Marketed | 2003 |
| BACLOFEN INJECTION0.05 mg / 1 ml · Solution | Baclofen | Canada | Marketed | 2014 |
| BACLOFEN INJECTION10 mg / 5 ml · Solution | Baclofen | Canada | Marketed | 2014 |
| BACLOFEN INJECTION10 mg / 20 ml · Solution | Baclofen | Canada | Marketed | 2014 |
| BORTEZOMIB INJECTION2.5 mg / ml · Solution | Bortezomib | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP7.5 mg / ml · Solution | Bupivacaine | Canada | Marketed | 2018 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP2.5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP7.5 mg / ml · Solution | Bupivacaine | Canada | Not marketed | 2021 |